University College Dublin is at the forefront of groundbreaking AI research for transforming pre-eclampsia diagnosis.
Through a collaborative effort, a solution has been developed to assist clinicians in effectively diagnosing pre-eclampsia using intelligent risk stratification of patient data and biomarkers.
SAS, a renowned AI and analytics company, is providing the technology through AI_PREMie on SAS Viya hosted on Microsoft Azure.
Supported by funding from Science Foundation Ireland, the University College Dublin team identified key biomarkers with diagnostic and predictive capabilities to create an AI model for clinical decision-making.
AI_PREMie offers a pre-eclampsia risk score with color-coded flags for clinical guidance and incorporates essential clinical data and demographic information for a comprehensive patient view.
The collaboration with SAS and Microsoft aims to enhance healthcare outcomes using data-driven solutions like AI_PREMie, which will be trialled in Dublin hospitals before global implementation.
Furthermore, SAS Viya AI platform is also utilized in SAS Health, a new health platform that streamlines health data management, enhances data governance, and accelerates patient insights.
